GO
Loading...

Pfizer needs to up AstraZeneca's offer: Pro

Friday, 2 May 2014 | 5:00 AM ET

Savvas Neophytou, pharmaceutical analyst at Panmure Gordon, says Pfizer's increased offer for AstraZeneca is a significant step and explains that a third bid is to be expected.